HI SCR241 | 2020 | Regular Session

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on March 6 2020 - 25% progression
Action: 2020-03-10 - Referred to CPH.
Pending: Senate Commerce, Consumer Protection, and Health Committee
Text: Latest bill text (Introduced) [HTML]

Summary

Requesting The Department Of Health To Convene A Medicinal Psilocybin Working Group To Examine The Medicinal And Therapeutic Effects Of Psilocybin And Develop A Longterm Strategic Plan To Ensure The Availability Of Medicinal Psilocybin Or Psilocybin-based Products That Are Safe, Accessible, And Affordable For Eligible Adult Patients.

Tracking Information

Register now for our free OneVote public service or GAITS Professional trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Requesting The Department Of Health To Convene A Medicinal Psilocybin Working Group To Examine The Medicinal And Therapeutic Effects Of Psilocybin And Develop A Longterm Strategic Plan To Ensure The Availability Of Medicinal Psilocybin Or Psilocybin-based Products That Are Safe, Accessible, And Affordable For Eligible Adult Patients.

Sponsors


History

DateChamberAction
2020-03-10SenateReferred to CPH.
2020-03-06SenateOffered.

Subjects


Hawaii State Sources


Bill Comments

feedback